Adicet Bio (ACET) Stock Forecast & Price Target

$0.97 -0.06 (-5.84%)

(As of 11/20/2024 ET)

Adicet Bio - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 4 Analyst Ratings

Sell
0

Hold
1

Buy
3

Based on 4 Wall Street analysts who have issued ratings for Adicet Bio in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a hold rating, and 3 have given a buy rating for ACET.

Consensus Price Target

$7.50
675.51% Upside

According to the 4 analysts' twelve-month price targets for Adicet Bio, the average price target is $7.50. The highest price target for ACET is $10.00, while the lowest price target for ACET is $5.00. The average price target represents a forecasted upside of 675.51% from the current price of $0.97.

Get the Latest News and Ratings for ACET and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Adicet Bio and its competitors.

ACET Analyst Ratings Over Time

Type	Current Forecast 11/22/23 to 11/21/24	1 Month Ago 10/23/23 to 10/22/24	3 Months Ago 8/24/23 to 8/23/24	1 Year Ago 11/22/22 to 11/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$7.50	$7.50	$15.25	$15.50
Forecasted Upside	675.51% Upside	393.42% Upside	923.49% Upside	1,247.83% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Buy	Moderate Buy

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

ACET Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ACET Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Adicet Bio Stock vs. The Competition

Type	Adicet Bio	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	675.51% Upside	26,931.56% Upside	9.82% Upside
News Sentiment Rating	Neutral News See Recent ACET News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/18/2024	HC Wainwright 2 of 5 stars	E. White Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral
11/7/2024	Wedbush 4 of 5 stars		Reiterated Rating	Outperform	$5.00	+275.94%
9/30/2024	Guggenheim 3 of 5 stars	M. Schmidt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold ➝ Buy	$7.00	+366.66%
9/11/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$19.00 ➝ $8.00	+478.87%
9/6/2023	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$27.00	+1,383.51%
8/10/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$20.00 ➝ $10.00	+321.94%
Get the Latest News and Ratings for ACET and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Adicet Bio and its competitors with MarketBeat's FREE daily newsletter.
6/27/2023	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reni Benjamin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
6/1/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Neutral	$20.00 ➝ $6.00	+9.49%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:35 AM ET.

ACET Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Adicet Bio is $7.50, with a high forecast of $10.00 and a low forecast of $5.00.
: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Adicet Bio in the last year. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ACET shares.
: According to analysts, Adicet Bio's stock has a predicted upside of 675.51% based on their 12-month stock forecasts.
: Over the previous 90 days, Adicet Bio's stock had 1 downgrade by analysts.
: Adicet Bio has been rated by research analysts at Canaccord Genuity Group, Guggenheim, HC Wainwright, and Wedbush in the past 90 days.
: Analysts like Adicet Bio less than other "medical" companies. The consensus rating score for Adicet Bio is 2.75 while the average consensus rating score for "medical" companies is 2.80. Learn more on how ACET compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

This page (NASDAQ:ACET) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adicet Bio (ACET) Stock Forecast & Price Target